Federal government agencies periodically call public meetings where interested parties can share their views on issues that have a potential impact on the field of transfusion medicine and cellular or biological therapies.
This section includes information on current and past meetings, including meeting summaries, resources and analysis as well as quick links to other relevant materials.
FDA Public Workshop on Hemoglobin Standards and Maintaining Adequate Iron Stores in Blood Donors – 11/8-9/11
FDA Workshop on Quarantine Release Errors – 9/13/11
NRC Public Meeting on Cesium Chloride Uses, Including Blood Irradiators - 9/29-9/30/08
FDA Public Workshop on the Licensure of Apheresis Blood Products - 8/15/07
FDA Public Meeting on National Drug Code - 12/11/06